EZH2 and melanoma: Our results and the previously described repression of miR-129 via EZH2 in different entities by DNA methylation or histone modification [43,64] let us conclude, that in BRAF mutated melanoma suppression of miR-129-5p is mediated via EZH2 downstream of constitutive active BRAF signaling.